Cantiller, Kheza .

HRN: 26-21-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2024
MUPIROCIN 2%, 15G (TUBE)
11/25/2024
12/02/2024
TOPICAL
15g
BID
S/P LSTCS
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes